Nutrasource Blog

In this special series, we highlight a member of the Nutrasource team so you can get better acquainted with the experts behind your project.

Clinical research is an important investment for the entire supply chain, from ingredient companies to brands selling finished health products. Primary research serves many purposes, and is most commonly used to validate efficacy, safety, and substantiate claims that increase the impact of a company’s marketing messages.

The Western world is hungry for health products, and industry is meeting that demand with increased product innovation and global expansion like never before. In Canada, consumer health products are categorized as foods, drugs, cosmetics, and natural health products (NHPs). NHPs (referred to as dietary supplements in the U.S.) are health products sold in traditional medicinal formats. Vitamins and minerals, protein powders, herbal medicines, probiotics, and many others, are all examples of products that are sold as NHPs. A 2010 survey showed that 73% of Canadians consume NHPs regularly, proving Canadian consumers are more interested in alternative health products than ever before.

It’s no secret that probiotics are dominating the supplement market, and the consumer demand for foods and supplements that contain beneficial bacteria is increasing exponentially. In fact, the probiotics market is predicted to be worth $69.3 billion by the year 2023.

Transparency was nothing more than a buzzword a few years ago. It has since quickly evolved into a strategic marketing opportunity for companies seeking a competitive advantage.

Now, transparency is a requirement for supplement brands that want to win the hearts (and dollars) of modern consumers.

Read on to learn how transparency can be prioritized to satisfy both your business goals and your end customer.

As the cannabidiol (CBD) market continues to gain steam, global regulators are working to carve out or update legal pathways to market. This makes keeping up—and staying compliant—an ongoing challenge for brands.

In this special series, we highlight a member of the Nutrasource team so you can get better acquainted with the experts behind your project.

What if you could develop one dietary supplement, with a single product specification, and sell it in multiple countries simultaneously – with no reformulation or regulatory headaches involved?

In this special series, we highlight a member of the Nutrasource team so you can get better acquainted with the experts behind your project.

Note: This article pertains to the United States. Products sold elsewhere are subject to different country/region-specific regulations.

Mandatory label compliance deadlines are drawing near. If you sell, or are planning on selling, a dietary supplement or food in the U.S., here is what you need to know about the updates required and how you can comply.

In addition to the changes to nutrition labeling, due for most companies January 1, 2020, FDA has set an official “uniform compliance date” of January 1, 2022 for final food and dietary supplement label regulations issued in 2019 and 2020. This compliance date also applies to the National Bioengineered Food Disclosure Standard.

With so many label updates coming in the near future, will your brand ready?